慢性乙肝完全病毒抑制后体重指数纵向变化与ALT升高的关联
本研究为前瞻性队列,纳入1965例接受核苷(酸)类似物治疗且HBV DNA持续检测不到至少6个月的慢性乙肝患者,每6个月随访。中位随访18.36个月,约三分之一患者出现ALT升高。基线高BMI(≥25 kg/m2)、较年轻年龄和肝硬化独立增加ALT纵向升高风险;随访结束时BMI由高转低者ALT升高风险降低(aOR 0.38,95%CI 0.19-0.77),由低转高者风险增加(aOR 1.78,95%CI 1.02-3.11)。
要点
- 完全病毒抑制后约1/3慢性乙肝患者仍出现ALT升高。
- 基线BMI≥25 kg/m2、年轻年龄、肝硬化独立增加ALT升高风险。
- BMI由高转低可降低ALT升高风险,由低转高则增加风险。
核心结论
- 高BMI是完全HBV DNA抑制后ALT升高的独立预测因素。
- 改善BMI可能有助于ALT正常化及长期结局。
研究设计与样本
- 前瞻性队列研究,纳入1965例接受核苷(酸)类似物治疗且HBV DNA持续检测不到至少6个月的慢性乙肝患者。
- 每6个月随访,进行人体测量、生化和病毒学评估,中位随访18.36个月。
主要发现
- 约三分之一患者出现ALT升高。
- 基线高BMI(≥25 kg/m2)、较年轻年龄和肝硬化独立增加ALT纵向升高风险。
- 随访结束时89例(4.8%)由高BMI转为低BMI,92例(5.0%)由低BMI转为高BMI。
- 与持续高BMI相比,转为低BMI降低ALT升高风险(aOR 0.38;95%CI 0.19-0.77)。
- 与持续低BMI相比,转为高BMI增加ALT升高风险(aOR 1.78;95%CI 1.02-3.11)。
临床怎么用
- 对完全病毒抑制的慢性乙肝患者应关注BMI变化,将其作为ALT升高的可干预因素。
- 体重管理可能有助于改善ALT正常化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Little is known about cause and intervention for alanine aminotransferase (ALT) elevation after complete viral suppression in patients with chronic hepatitis B (CHB). METHODS: In this prospective cohort study, patients with CHB who were treated with nucleos(t)ide analogs and maintained undetectable levels of hepatitis B virus (HBV) deoxyribonucleic acid (DNA) for at least 6 months were enrolled. Patients were followed up at 6-month intervals, and anthropometric, biochemical, and virological assessments were performed. RESULTS: Of 1965 patients with median follow-up of 18.36 months, one third of patients experienced ALT elevation. Baseline high body mass index ([BMI] defined as ≥25 kg/m2), younger age, and liver cirrhosis independently increased the risk of longitudinal ALT elevation. At the end of follow-up, 89 (4.8%) patients reverted to low BMI, and 92 (5.0%) developed to high BMI. Compared with persistent high BMI, reversion to low BMI reduced the risk of ALT elevation (adjusted odds ratio [aOR], 0.38; 95% confidence interval [CI], 0.19-0.77); compared with persistent low BMI, onset of high BMI increased the risk of ALT elevation (aOR, 1.78; 95% CI, 1.02-3.11). CONCLUSIONS: High BMI is an independent predictor for ALT elevation after complete HBV DNA suppression. Improvement of BMI may have a beneficial effect on ALT normalization and even long-term outcomes.
引用
- Wang K, Lin W, Kuang Z, et al. Longitudinal Change of Body Mass Index Is Associated With Alanine Aminotransferase Elevation After Complete Viral Suppression in Chronic Hepatitis B Patients. J Infect Dis. 2019. PMID: 31370059. doi:10.1093/infdis/jiz326
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。